CME Other Current Liab from 2010 to 2024
| CME Stock | USD 207.48 0.59 0.28% |
Other Current Liabilities | First Reported 2001-12-31 | Previous Quarter 93.3 B | Current Value 94.6 B | Quarterly Volatility 45.3 B |
Check CME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CME main balance sheet or income statement drivers, such as Depreciation And Amortization of 370.2 M, Interest Expense of 107.7 M or Selling And Marketing Expenses of 171 M, as well as many exotic indicators such as Price To Sales Ratio of 8.04, Dividend Yield of 0.0235 or PTB Ratio of 3.8. CME financial statements analysis is a perfect complement when working with CME Valuation or Volatility modules.
CME | Other Current Liab |
Latest CME's Other Current Liab Growth Pattern
Below is the plot of the Other Current Liab of CME Group over the last few years. It is CME's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CME's overall financial position and show how it may be relating to other accounts over time.
| Other Current Liab | 10 Years Trend |
|
Other Current Liab |
| Timeline |
CME Other Current Liab Regression Statistics
| Arithmetic Mean | 56,816,780,800 | |
| Geometric Mean | 30,647,840,038 | |
| Coefficient Of Variation | 82.89 | |
| Mean Deviation | 38,287,041,467 | |
| Median | 40,582,400,000 | |
| Standard Deviation | 47,093,022,128 | |
| Sample Variance | 2217752733.2T | |
| Range | 159.4B | |
| R-Value | 0.85 | |
| Mean Square Error | 661534483.2T | |
| R-Squared | 0.72 | |
| Significance | 0.000059 | |
| Slope | 8,953,967,593 | |
| Total Sum of Squares | 31048538264.2T |
CME Other Current Liab History
About CME Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include CME income statement, its balance sheet, and the statement of cash flows. CME investors use historical funamental indicators, such as CME's Other Current Liab, to determine how well the company is positioned to perform in the future. Although CME investors may use each financial statement separately, they are all related. The changes in CME's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CME's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CME Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CME. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Current Liabilities | 93.3 B | 98 B |
Pair Trading with CME
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.Moving together with CME Stock
| 0.69 | ICE | Intercontinental Exchange | PairCorr |
Moving against CME Stock
| 0.6 | FG | FG Annuities Life | PairCorr |
| 0.5 | DHIL | Diamond Hill Investment Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of CME Correlation against competitors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 4.45 | Earnings Share 8.78 | Revenue Per Share 15.637 | Quarterly Revenue Growth 0.034 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.